-
1
-
-
0029119083
-
Cutaneous metastatic disease
-
Schwartz RA. Cutaneous metastatic disease. J Am Acad Dermatol 1995;33:161-82.
-
(1995)
J Am Acad Dermatol
, vol.33
, pp. 161-182
-
-
Schwartz, R.A.1
-
2
-
-
36048958259
-
Tumor invasion of the skin
-
DOI 10.1016/j.det.2007.08.004, PII S0733863507000939, Internal Malignancy and the Skin: Paraneoplastic and Cancer Treatment-Related Cutaneous Disorder
-
Rolz-Cruz G, Kim CC. Tumor invasion of the skin. Dermatol Clin 2008;26:89 - 102, viii. (Pubitemid 350102012)
-
(2008)
Dermatologic Clinics
, vol.26
, Issue.1
, pp. 89-102
-
-
Rolz-Cruz, G.1
Kim, C.C.2
-
4
-
-
0032127362
-
Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin
-
DOI 10.1002/(SICI)1097-0142(19980701)83:1<148::AID-CNCR20>3.0.CO;2- W
-
Heller R, Jaroszeski MJ, Reintgen DS, Puleo CA, DeConti RC, Gilbert RA, et al. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer 1998;83:148-57. (Pubitemid 28299641)
-
(1998)
Cancer
, vol.83
, Issue.1
, pp. 148-157
-
-
Heller, R.1
Jaroszeski, M.J.2
Reintgen, D.S.3
Puleo, C.A.4
DeConti, R.C.5
Gilbert, R.A.6
Glass, L.F.7
-
5
-
-
33751035728
-
Electrochemotherapy - An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study
-
DOI 10.1016/j.ejcsup.2006.08.002, PII S1359634906001868
-
Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, et al. Electrochemotherapy, An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. EJC Supplements 2006;4:3-13. (Pubitemid 44755131)
-
(2006)
European Journal of Cancer, Supplement
, vol.4
, Issue.11
, pp. 3-13
-
-
Marty, M.1
Sersa, G.2
Garbay, J.R.3
Gehl, J.4
Collins, C.G.5
Snoj, M.6
Billard, V.7
Geertsen, P.F.8
Larkin, J.O.9
Miklavcic, D.10
Pavlovic, I.11
Paulin-Kosir, S.M.12
Cemazar, M.13
Morsli, N.14
Soden, D.M.15
Rudolf, Z.16
Robert, C.17
O'Sullivan, G.C.18
Mir, L.M.19
-
6
-
-
0031776828
-
Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy
-
Mir LM, Glass LF, Sersa G, Teissie J, Domenge C, Miklavcic D, et al. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer 1998;77:2336-42. (Pubitemid 28263963)
-
(1998)
British Journal of Cancer
, vol.77
, Issue.12
, pp. 2336-2342
-
-
Mir, L.M.1
Glass, L.F.2
Sersa, G.3
Teissie, J.4
Domenge, C.5
Miklavcic, D.6
Jaroszeski, M.J.7
Orlowski, S.8
Reintgen, D.S.9
Rudolf, Z.10
Belehradek, M.11
Gilbert, R.12
Rols, M.-P.13
Belehradek Jr., J.14
Bachaud, J.M.15
DeConti, R.16
Stabuc, B.17
Cemazar, M.18
Coninx, P.19
Heller, R.20
more..
-
7
-
-
0037383050
-
Electroporation: Theory and methods, perspectives for drug delivery, gene therapy and research
-
DOI 10.1046/j.1365-201X.2003.01093.x
-
Gehl J. Electroporation: Theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand 2003;177:437-47. (Pubitemid 36411581)
-
(2003)
Acta Physiologica Scandinavica
, vol.177
, Issue.4
, pp. 437-447
-
-
Gehl, J.1
-
8
-
-
0027385319
-
Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized
-
Tounekti O, Pron G, Belehradek J, Jr., Mir LM. Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res 1993;53:5462-9. (Pubitemid 23342168)
-
(1993)
Cancer Research
, vol.53
, Issue.22
, pp. 5462-5469
-
-
Tounekti, O.1
Pron, G.2
Belehradek Jr., J.3
Mir, L.M.4
-
9
-
-
0031779576
-
Enhancement of cytotoxicity by electropermeabilization: An improved method for screening drugs
-
Gehl J, Skovsgaard T, Mir LM. Enhancement of cytotoxicity by electropermeabilization: An improved method for screening drugs. Anticancer Drugs 1998;9:319-25. (Pubitemid 28241821)
-
(1998)
Anti-Cancer Drugs
, vol.9
, Issue.4
, pp. 319-325
-
-
Gehl, J.1
Skovsgaard, T.2
Mir, L.M.3
-
10
-
-
0024244839
-
Transient electropermeabilization of cells in culture: Increase of the cytotoxicity of anticancer drugs
-
DOI 10.1016/0006-2952(88)90344-9
-
Orlowski S, Belehradek Jr J, Paoletti C, Mir LM. Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 1988;37:4727-33. (Pubitemid 19006314)
-
(1988)
Biochemical Pharmacology
, vol.37
, Issue.24
, pp. 4727-4733
-
-
Orlowski, S.1
Belehradek Jr., J.2
Paoletti, C.3
Mir, L.M.4
-
11
-
-
0034100694
-
Toxicity of anticancer agents mediated by electroporation in vitro
-
DOI 10.1097/00001813-200003000-00008
-
Jaroszeski MJ, Dang V, Pottinger C, Hickey J, Gilbert R, Heller R. Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs 2000;11:201-8. (Pubitemid 30258800)
-
(2000)
Anti-Cancer Drugs
, vol.11
, Issue.3
, pp. 201-208
-
-
Jaroszeski, M.J.1
Dang, V.2
Pottinger, C.3
Hickey, J.4
Gilbert, R.5
Heller, R.6
-
12
-
-
0027142891
-
Electrochemotherapy, a new antitumor treatment: First clinical Phase I-II trial
-
DOI 10.1002/1097-0142(19931215)72:12<3694::AID-CNCR2820721222>3.0. CO;2-2
-
Belehradek M, Domenge C, Luboinski B, Orlowski S, Belehradek J, Jr., Mir LM. Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer 1993;72:3694-700. (Pubitemid 24000606)
-
(1993)
Cancer
, vol.72
, Issue.12
, pp. 3694-3700
-
-
Belehradek, M.1
Domenge, C.2
Luboinski, B.3
Orlowski, S.4
Belehradek Jr., J.5
Mir, L.M.6
-
13
-
-
58549110914
-
Bleomycin-based electrochemotherapy: Clinical outcome from a single institution's experience with 52 patients
-
Campana LG, Mocellin S, Basso M, Puccetti O, De Salvo GL, Chiarion-Sileni V, et al. Bleomycin-based electrochemotherapy: Clinical outcome from a single institution's experience with 52 patients. Ann Surg Oncol 2009;16:191-9.
-
(2009)
Ann Surg Oncol
, vol.16
, pp. 191-199
-
-
Campana, L.G.1
Mocellin, S.2
Basso, M.3
Puccetti, O.4
De Salvo, G.L.5
Chiarion-Sileni, V.6
-
14
-
-
0141502361
-
Electrochemotherapy: Results of cancer treatment using enhanced delivery of bleomycin by electroporation
-
DOI 10.1016/S0305-7372(03)00073-2
-
Gothelf A, Mir LM, Gehl J. Electrochemotherapy: Results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev 2003;29:371-87. (Pubitemid 37185104)
-
(2003)
Cancer Treatment Reviews
, vol.29
, Issue.5
, pp. 371-387
-
-
Gothelf, A.1
Mir, L.M.2
Gehl, J.3
-
15
-
-
0034963996
-
Electrochemotherapy in primary and metastatic skin tumors: Phase II trial using intralesional bleomycin
-
DOI 10.1016/S0188-4409(01)00278-8, PII S0188440901002788
-
Rodriguez-Cuevas S, Barroso-Bravo S, Manza-Estrada J, Cristobal-Martinez L, Gonzalez-Rodriguez E. Electrochemotherapy in primary and metastatic skin tumors: Phase II trial using intralesional bleomycin. Arch Med Res 2001;32:273-6. (Pubitemid 32611639)
-
(2001)
Archives of Medical Research
, vol.32
, Issue.4
, pp. 273-276
-
-
Rodriguez-Cuevas, S.1
Barroso-Bravo, S.2
Almanza-Estrada, J.3
Cristobal-Martinez, L.4
Gonzalez-Rodriguez, E.5
-
16
-
-
0034534023
-
Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy
-
DOI 10.1097/00008390-200012000-00011
-
Gehl J, Geertsen PF. Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy. Melanoma Res 2000;10:585-9. (Pubitemid 32011982)
-
(2000)
Melanoma Research
, vol.10
, Issue.6
, pp. 585-589
-
-
Gehl, J.1
Geertsen, P.F.2
-
17
-
-
33751051150
-
TM by means of invasive or non-invasive electrodes
-
DOI 10.1016/j.ejcsup.2006.08.003, PII S135963490600187X
-
Mir LM, Gehl J, Sersa G, Collins CG, Garbay JR, Billard V, et al. Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes. EJC Supplements 2006;4:14-25. (Pubitemid 44755132)
-
(2006)
European Journal of Cancer, Supplement
, vol.4
, Issue.11
, pp. 14-25
-
-
Mir, L.M.1
Gehl, J.2
Sersa, G.3
Collins, C.G.4
Garbay, J.-R.5
Billard, V.6
Geertsen, P.F.7
Rudolf, Z.8
O'Sullivan, G.C.9
Marty, M.10
-
18
-
-
0030047319
-
Antitumor electrochemotherapy: New advances in the clinical protocol
-
DOI 10.1002/(SICI)1097-0142(19960301)77:5<956::AID-CNCR23>3.0.CO;2- 1
-
Domenge C, Orlowski S, Luboinski B, De BT, Schwaab G, Belehradek J, Jr., et al. Antitumor electrochemotherapy: New advances in the clinical protocol. Cancer 1996;77:956-63. (Pubitemid 26061292)
-
(1996)
Cancer
, vol.77
, Issue.5
, pp. 956-963
-
-
Domenge, C.1
Orlowski, S.2
Luboinski, B.3
De Baere, T.4
Schwaab, G.5
Belehradek Jr., J.6
Mir, L.M.7
-
19
-
-
0019941944
-
Bleomycin clinical pharmacology by radioimmunoassay
-
DOI 10.1007/BF00296756
-
Hall SW, Strong JE, Broughton A, Frazier ML, Benjamin RS. Bleomycin clinical pharmacology by radioimmunoassay. Cancer Chemother Pharmacol 1982;9:22-5. (Pubitemid 12029232)
-
(1982)
Cancer Chemotherapy and Pharmacology
, vol.9
, Issue.1
, pp. 22-25
-
-
Hall, S.W.1
Strong, J.E.2
Brouhgton, A.3
-
20
-
-
0029094143
-
Bleomycin and hyperoxia exposure in the operating room
-
Mathes DD. Bleomycin and hyperoxia exposure in the operating room. Anesth Analg 1995;81:624-9.
-
(1995)
Anesth Analg
, vol.81
, pp. 624-629
-
-
Mathes, D.D.1
-
21
-
-
0034594628
-
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
-
Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-16.
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 205-216
-
-
Therasse, P.1
Arbuck, S.G.2
Eisenhauer, E.A.3
Wanders, J.4
Kaplan, R.S.5
Rubinstein, L.6
-
22
-
-
0026264930
-
Electrochemotherapy a new antitumor treatment: First clinical trial
-
Mir LM, Belehradek M, Domenge C, Orlowski S, Poddevin B, Belehradek J, Jr., et al. [Electrochemotherapy, a new antitumor treatment: First clinical trial]. C R Acad Sci III 1991; 313:613-8.
-
(1991)
C R Acad Sci III
, vol.313
, pp. 613-618
-
-
Mir, L.M.1
Belehradek, M.2
Domenge, C.3
Orlowski, S.4
Poddevin, B.5
Belehradek Jr., J.6
-
23
-
-
48149097202
-
Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases
-
Quaglino P, Mortera C, Osella-Abate S, Barberis M, Illengo M, Rissone M, et al. Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases. Ann Surg Oncol 2008;15:2215-22.
-
(2008)
Ann Surg Oncol
, vol.15
, pp. 2215-2222
-
-
Quaglino, P.1
Mortera, C.2
Osella-Abate, S.3
Barberis, M.4
Illengo, M.5
Rissone, M.6
-
24
-
-
33749432108
-
How we do it: Chemo-electroporation in the head and neck for otherwise untreatable patients
-
DOI 10.1111/j.1749-4486.2006.01198.x
-
Tijink BM, De BR, Van Dongen GA, Leemans CR. How we do it: Chemo-electroporation in the head and neck for otherwise untreatable patients. Clin Otolaryngol 2006; 31:447-51. (Pubitemid 44511170)
-
(2006)
Clinical Otolaryngology
, vol.31
, Issue.5
, pp. 447-451
-
-
Tijink, B.M.1
De Bree, R.2
Van Dongen, G.A.M.S.3
Leemans, C.R.4
-
25
-
-
34247576877
-
Electrochemotherapy: Aspects of preclinical development and early clinical experience
-
DOI 10.1097/01.sla.0000250419.36053.33, PII 0000065820070300000019
-
Larkin JO, Collins CG, Aarons S, Tangney M, Whelan M, O'Reily S, et al. Electrochemotherapy: Aspects of preclinical development and early clinical experience. Ann Surg 2007; 245:469-79. (Pubitemid 46673144)
-
(2007)
Annals of Surgery
, vol.245
, Issue.3
, pp. 469-479
-
-
Larkin, J.O.1
Collins, C.G.2
Aarons, S.3
Tangney, M.4
Whelan, M.5
O'Reily, S.6
Breathnach, O.7
Soden, D.M.8
O'Sullivan, G.C.9
|